首页> 外国专利> Methods and therapeutic compositions for utilization of adenosine 5'-triphosphate (ATP) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)

Methods and therapeutic compositions for utilization of adenosine 5'-triphosphate (ATP) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)

机译:利用5'-三磷酸腺苷(ATP)治疗急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)的方法和治疗组合物

摘要

The invention discloses methods for the utilization of adenosine 5-triphosphate (ATP) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The administration of ATP results in several therapeutic activities, which by acting in consort provide the methods for treatment of ALI and ARDS. These therapeutic activities are 1. The utility of ATP as a preferential pulmonary vasodilator, 2. The utility of the catabolic product of ATP, adenosine, as an anti-inflammatory agent, 3. The anti-thrombotic, pro-fibrinolytic activities of ATP and adenosine, and 4. The utility of ATP in improving organ and muscle function in advanced disease patients. Therapeutic compositions and procedures for treating ALI and ARDS by administration of ATP are provided.
机译:本发明公开了利用5-三磷酸腺苷(ATP)治疗急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)的方法。 ATP的给药可产生多种治疗活性,通过共同作用提供了治疗ALI和ARDS的方法。这些治疗活性是:1. ATP作为优先的肺血管扩张剂的用途; 2. ATP的分解代谢产物腺苷作为抗炎剂的用途; 3. ATP的抗血栓形成,促纤溶活性和腺苷和4. ATP在改善晚期疾病患者的器官和肌肉功能中的作用。提供了通过给予ATP来治疗ALI和ARDS的治疗组合物和程序。

著录项

  • 公开/公告号US2003109486A1

    专利类型

  • 公开/公告日2003-06-12

    原文格式PDF

  • 申请/专利权人 RAPAPORT ELIEZER;

    申请/专利号US20020284096

  • 发明设计人 ELIEZER RAPAPORT;

    申请日2002-10-31

  • 分类号A61K31/7076;A61L9/04;

  • 国家 US

  • 入库时间 2022-08-22 00:12:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号